vs
Side-by-side financial comparison of MEDIFAST INC (MED) and REGIS CORP (RGS). Click either name above to swap in a different company.
MEDIFAST INC is the larger business by last-quarter revenue ($75.1M vs $57.1M, roughly 1.3× REGIS CORP). On growth, REGIS CORP posted the faster year-over-year revenue change (22.3% vs -36.9%). REGIS CORP produced more free cash flow last quarter ($891.0K vs $-6.6M). Over the past eight quarters, REGIS CORP's revenue compounded faster (7.8% CAGR vs -34.4%).
Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.
REGIS CORPRGSEarnings & Financial Report
Regis Corporation is an American operator of hair salons. As of August 2021, it has 5,563 franchised and 276 company-owned salons. Its headquarters are in Minneapolis, Minnesota.
MED vs RGS — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $75.1M | $57.1M |
| Net Profit | — | $456.0K |
| Gross Margin | 69.4% | — |
| Operating Margin | -10.4% | 10.8% |
| Net Margin | — | 0.8% |
| Revenue YoY | -36.9% | 22.3% |
| Net Profit YoY | — | -94.0% |
| EPS (diluted) | $-1.64 | $0.16 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $75.1M | $57.1M | ||
| Q3 25 | $89.4M | $59.0M | ||
| Q2 25 | $105.6M | $60.4M | ||
| Q1 25 | $115.7M | $57.0M | ||
| Q4 24 | $119.0M | $46.7M | ||
| Q3 24 | $140.2M | $46.1M | ||
| Q2 24 | $168.6M | $49.4M | ||
| Q1 24 | $174.7M | $49.2M |
| Q4 25 | — | $456.0K | ||
| Q3 25 | $-2.3M | $1.4M | ||
| Q2 25 | $2.5M | $116.5M | ||
| Q1 25 | $-772.0K | $250.0K | ||
| Q4 24 | — | $7.6M | ||
| Q3 24 | $1.1M | $-853.0K | ||
| Q2 24 | $-8.2M | $91.2M | ||
| Q1 24 | $8.3M | $-2.3M |
| Q4 25 | 69.4% | — | ||
| Q3 25 | 69.5% | — | ||
| Q2 25 | 72.6% | — | ||
| Q1 25 | 72.8% | — | ||
| Q4 24 | 74.1% | — | ||
| Q3 24 | 75.4% | — | ||
| Q2 24 | 73.2% | — | ||
| Q1 24 | 72.8% | — |
| Q4 25 | -10.4% | 10.8% | ||
| Q3 25 | -4.6% | 10.0% | ||
| Q2 25 | -1.0% | 12.1% | ||
| Q1 25 | -1.1% | 8.8% | ||
| Q4 24 | 0.6% | 11.8% | ||
| Q3 24 | 1.5% | 4.6% | ||
| Q2 24 | -4.7% | — | ||
| Q1 24 | 4.5% | 8.3% |
| Q4 25 | — | 0.8% | ||
| Q3 25 | -2.5% | 2.3% | ||
| Q2 25 | 2.3% | 192.9% | ||
| Q1 25 | -0.7% | 0.4% | ||
| Q4 24 | — | 16.4% | ||
| Q3 24 | 0.8% | -1.9% | ||
| Q2 24 | -4.8% | 184.7% | ||
| Q1 24 | 4.8% | -4.7% |
| Q4 25 | $-1.64 | $0.16 | ||
| Q3 25 | $-0.21 | $0.49 | ||
| Q2 25 | $0.22 | $43.67 | ||
| Q1 25 | $-0.07 | $0.08 | ||
| Q4 24 | $0.08 | $2.71 | ||
| Q3 24 | $0.10 | $-0.36 | ||
| Q2 24 | $-0.75 | $38.40 | ||
| Q1 24 | $0.76 | $-1.00 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $167.3M | $18.4M |
| Total DebtLower is stronger | — | $113.3M |
| Stockholders' EquityBook value | $198.9M | $188.7M |
| Total Assets | $248.0M | $588.3M |
| Debt / EquityLower = less leverage | — | 0.60× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $167.3M | $18.4M | ||
| Q3 25 | $173.5M | $16.6M | ||
| Q2 25 | $162.7M | $17.0M | ||
| Q1 25 | $164.6M | $13.3M | ||
| Q4 24 | $162.3M | $10.2M | ||
| Q3 24 | $170.0M | $6.3M | ||
| Q2 24 | $163.5M | $10.1M | ||
| Q1 24 | $156.4M | $5.9M |
| Q4 25 | — | $113.3M | ||
| Q3 25 | — | $111.3M | ||
| Q2 25 | — | $110.8M | ||
| Q1 25 | — | $112.0M | ||
| Q4 24 | — | $111.5M | ||
| Q3 24 | — | $95.2M | ||
| Q2 24 | — | $99.5M | ||
| Q1 24 | — | $179.7M |
| Q4 25 | $198.9M | $188.7M | ||
| Q3 25 | $214.7M | $187.6M | ||
| Q2 25 | $216.0M | $185.6M | ||
| Q1 25 | $211.0M | $68.6M | ||
| Q4 24 | $210.1M | $66.7M | ||
| Q3 24 | $207.3M | $56.4M | ||
| Q2 24 | $205.3M | $56.8M | ||
| Q1 24 | $211.0M | $-35.8M |
| Q4 25 | $248.0M | $588.3M | ||
| Q3 25 | $268.2M | $592.1M | ||
| Q2 25 | $269.3M | $599.0M | ||
| Q1 25 | $280.0M | $511.2M | ||
| Q4 24 | $284.2M | $530.1M | ||
| Q3 24 | $291.2M | $508.9M | ||
| Q2 24 | $293.5M | $530.5M | ||
| Q1 24 | $302.8M | $543.7M |
| Q4 25 | — | 0.60× | ||
| Q3 25 | — | 0.59× | ||
| Q2 25 | — | 0.60× | ||
| Q1 25 | — | 1.63× | ||
| Q4 24 | — | 1.67× | ||
| Q3 24 | — | 1.69× | ||
| Q2 24 | — | 1.75× | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-5.3M | $1.7M |
| Free Cash FlowOCF − Capex | $-6.6M | $891.0K |
| FCF MarginFCF / Revenue | -8.8% | 1.6% |
| Capex IntensityCapex / Revenue | 1.8% | 1.4% |
| Cash ConversionOCF / Net Profit | — | 3.65× |
| TTM Free Cash FlowTrailing 4 quarters | $1.2M | $14.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-5.3M | $1.7M | ||
| Q3 25 | $12.1M | $2.3M | ||
| Q2 25 | $-3.4M | $6.8M | ||
| Q1 25 | $3.4M | $6.2M | ||
| Q4 24 | $-4.9M | $2.1M | ||
| Q3 24 | $9.1M | $-1.3M | ||
| Q2 24 | $13.1M | $5.1M | ||
| Q1 24 | $7.3M | $-277.0K |
| Q4 25 | $-6.6M | $891.0K | ||
| Q3 25 | $10.8M | $1.9M | ||
| Q2 25 | $-4.8M | $6.2M | ||
| Q1 25 | $1.9M | $5.9M | ||
| Q4 24 | $-7.2M | $1.7M | ||
| Q3 24 | $7.7M | $-1.4M | ||
| Q2 24 | $11.1M | $5.1M | ||
| Q1 24 | $5.4M | $-326.0K |
| Q4 25 | -8.8% | 1.6% | ||
| Q3 25 | 12.0% | 3.2% | ||
| Q2 25 | -4.5% | 10.3% | ||
| Q1 25 | 1.6% | 10.3% | ||
| Q4 24 | -6.1% | 3.6% | ||
| Q3 24 | 5.5% | -3.0% | ||
| Q2 24 | 6.6% | 10.3% | ||
| Q1 24 | 3.1% | -0.7% |
| Q4 25 | 1.8% | 1.4% | ||
| Q3 25 | 1.5% | 0.7% | ||
| Q2 25 | 1.3% | 0.9% | ||
| Q1 25 | 1.3% | 0.6% | ||
| Q4 24 | 1.9% | 0.9% | ||
| Q3 24 | 1.0% | 0.0% | ||
| Q2 24 | 1.1% | 0.0% | ||
| Q1 24 | 1.1% | 0.1% |
| Q4 25 | — | 3.65× | ||
| Q3 25 | — | 1.68× | ||
| Q2 25 | -1.36× | 0.06× | ||
| Q1 25 | — | 24.80× | ||
| Q4 24 | — | 0.28× | ||
| Q3 24 | 8.04× | — | ||
| Q2 24 | — | 0.06× | ||
| Q1 24 | 0.88× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MED
Segment breakdown not available.
RGS
| Franchise Segment | $37.9M | 66% |
| Royalty | $13.6M | 24% |
| Other | $2.8M | 5% |
| Fees | $1.8M | 3% |
| Franchise Fees | $1.0M | 2% |
